Ebolavirus Disease (EVD) is a severe haemorrhagic fever that occurs in epidemic
outbreaks, with a high fatality rate and no specific therapies available. rVSVΔG-ZEBOV-GP …

Background A recombinant vesicular stomatitis virus vector expressing the Zaire Ebola virus
glycoprotein (rVSVΔG-ZEBOV-GP) vaccine has been reported as safe, immunogenic, and …

Ebola virus disease is a deadly infection which occurs in sporadic outbreaks. Several
vaccine candidates have been developed. The most advanced candidate is the recombinant …

Background During the last decade Ebola virus has caused several outbreaks in Africa. The
recombinant vesicular stomatitis virus-vectored Zaire Ebola (rVSVΔG-ZEBOV-GP) vaccine …

The 2014–2015 Ebola epidemic affected several African countries, claiming more than
11,000 lives and leaving thousands with ongoing sequelae. Safe and effective vaccines …

Vesicular stomatitis virus expressing Zaire Ebola virus (EBOV) glycoprotein
(VSVΔG/EBOVgp) could be used as a vaccine to meet the 2014 Ebola virus outbreak. To …

Highlights•An effective Ebola vaccine would be of critical importance for preventing the
disease in high risk areas.•rVSV-ZEBOV is the only Ebola vaccine with demonstrated …

Abstract Background The recent West African Ebola epidemic led to accelerated efforts to
test Ebola vaccine candidates. As part of the World Health Organisation-led VSV Ebola …

Ebola virus (EBOV) is a single-stranded RNA virus that causes Ebola virus disease (EVD),
characterized by excessive inflammation, lymphocyte apoptosis, hemorrhage, and …

Ebola virus (EBOV), a member of the Filoviridae family, causes the most severe form of viral
hemorrhagic fever. Although no FDA licensed vaccine or treatment against Ebola virus …